Effects of Mulligan Mobilization With Movement as Compared to Kaltenborn Joint Mobilization in the Management of Knee Osteoarthritis

June 5, 2024 updated by: Foundation University Islamabad
This study is a randomised controlled trial and the purpose of this study is to determine the Effects of Mulligan mobilization with movement as compared to Kaltenborn joint mobilization in the management of knee osteoarthritis." To determine the effects of Mulligan MWM as compared to Kaltenborn joint mobilization in terms of pain, function, range of motion and gait in persons with knee osteoarthritis.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Islamabad, Pakistan
        • Foundation University Islamabad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Individuals aged 40-70 years (Osama et al, 2022)
  • Having KOA history of no less than 3 months
  • Knee pain less than 8/10 on numeric pain rating scale (NPRS).
  • Radiological evidence of grade III or less on Kellgren classification
  • Patients referred from rehab department

Exclusion Criteria:

  • Those with signs of serious pathology, such as malignancy, inflammatory disorder or infection.
  • History of trauma or fractures in lower extremity.
  • Signs of lumbar radiculopathy or myelopathy.
  • History of knee surgery or replacement.
  • Receiving intra-articular steroid therapy in the preceding two months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mulligan MWM group
Group A receiving Mulligan MWM joint mobilization
Heating pad will be used for heating purpose.
TENS is used for symptomatic pain relief
It provides short term pain relief and to restore pain-free, functional movements by achieving full range at the joint
Resistance training increases muscle strength by making your muscles work against a weight or force.
Experimental: Kaltenborn mobilization group
Group B receiving Kaltenborn Joint mobilization
Heating pad will be used for heating purpose.
TENS is used for symptomatic pain relief
Resistance training increases muscle strength by making your muscles work against a weight or force.
The purpose of joint mobilization is to restore normal, painless joint function. In restricted joints, this involves the restoration of joint play to normalize the roll-gliding that is essential to active movement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knee pain
Time Frame: 2 weeks
knee pain will be measured using visual analogue scale (VAS) from 0-100mm.A higher score on VAS indicated greater pain.
2 weeks
Functional disability
Time Frame: 2 weeks
knee functional disability will be assessed using Knee Osteoarthritis and Outcome Score(KOOS) with a score ranging from 0-100. A lower score on KOOS signifies greater functional disability
2 weeks
Knee range of motion
Time Frame: 2 weeks
knee range of motion will be measured using a goniometer. A higher ROM signifies positive outcome.
2 weeks
Stride length
Time Frame: 2 weeks
Gait analysis will be done to analyze stride length. A greater stride length signifies positive outcome and prognosis.
2 weeks
Gait velocity
Time Frame: 2 weeks
Gait analysis will be done to analyze gait velocity. A greater gait velocity signifies positive outcome and prognosis.
2 weeks
Isometeric Muscle Strength
Time Frame: 2 weeks
Isometeric Muscle Strength will be quantified using dynamometer. A higher score on dynamometer signifies greater muscle strength and good prognosis.
2 weeks
Walking related performance fatigability
Time Frame: 2 weeks
walking related performance fatigability will be measured using 6 minute walk test. Greater fatigibility indicates poorer outcome.
2 weeks
Functional Capacity
Time Frame: 2 weeks
5 repetition sit to stand test will be used to determine knee related functional capacity which will be quantified in terms of time. A smaller time will denote greater functional capacity.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shanza Fatima, DPT, Foundation University Islamabad
  • Principal Investigator: Muhammad Osama, PhD*, Foundation University Islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 10, 2024

Primary Completion (Estimated)

December 10, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

May 27, 2024

First Submitted That Met QC Criteria

June 5, 2024

First Posted (Actual)

June 6, 2024

Study Record Updates

Last Update Posted (Actual)

June 6, 2024

Last Update Submitted That Met QC Criteria

June 5, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • FUI/CTR/2024/13

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Heating pad

Subscribe